BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 28207746)

  • 1. Protease resistance of infectious prions is suppressed by removal of a single atom in the cellular prion protein.
    Leske H; Hornemann S; Herrmann US; Zhu C; Dametto P; Li B; Laferriere F; Polymenidou M; Pelczar P; Reimann RR; Schwarz P; Rushing EJ; Wüthrich K; Aguzzi A
    PLoS One; 2017; 12(2):e0170503. PubMed ID: 28207746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant PrPSc conformers induced by a synthetic peptide and several prion strains.
    Tremblay P; Ball HL; Kaneko K; Groth D; Hegde RS; Cohen FE; DeArmond SJ; Prusiner SB; Safar JG
    J Virol; 2004 Feb; 78(4):2088-99. PubMed ID: 14747574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and infectious prion diseases.
    Prusiner SB
    Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
    Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
    J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion acute synaptotoxicity is largely driven by protease-resistant PrPSc species.
    Foliaki ST; Lewis V; Finkelstein DI; Lawson V; Coleman HA; Senesi M; Islam AMT; Chen F; Sarros S; Roberts B; Adlard PA; Collins SJ
    PLoS Pathog; 2018 Aug; 14(8):e1007214. PubMed ID: 30089152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteinase K-sensitive disease-associated ovine prion protein revealed by conformation-dependent immunoassay.
    Thackray AM; Hopkins L; Bujdoso R
    Biochem J; 2007 Jan; 401(2):475-83. PubMed ID: 17018021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease-resistant and detergent-insoluble prion protein is not necessarily associated with prion infectivity.
    Shaked GM; Fridlander G; Meiner Z; Taraboulos A; Gabizon R
    J Biol Chem; 1999 Jun; 274(25):17981-6. PubMed ID: 10364247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of thermolysin in the diagnosis of prion diseases.
    Owen JP; Maddison BC; Whitelam GC; Gough KC
    Mol Biotechnol; 2007 Feb; 35(2):161-70. PubMed ID: 17435282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered distribution, aggregation, and protease resistance of cellular prion protein following intracranial inoculation.
    Ward A; Hollister JR; Choi YP; Race B; Williams K; Shoup DW; Moore RA; Priola SA
    PLoS One; 2019; 14(7):e0219457. PubMed ID: 31291644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ninth Datta Lecture. Molecular biology of transmissible spongiform encephalopathies.
    Weissmann C
    FEBS Lett; 1996 Jun; 389(1):3-11. PubMed ID: 8682199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of proteinase K-sensitive prions using pronase E and phosphotungstic acid.
    D'Castro L; Wenborn A; Gros N; Joiner S; Cronier S; Collinge J; Wadsworth JD
    PLoS One; 2010 Dec; 5(12):e15679. PubMed ID: 21187933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmissibility of H-Type Bovine Spongiform Encephalopathy to Hamster PrP Transgenic Mice.
    Okada H; Masujin K; Miyazawa K; Yokoyama T
    PLoS One; 2015; 10(10):e0138977. PubMed ID: 26466381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-genetic propagation of strain-specific properties of scrapie prion protein.
    Bessen RA; Kocisko DA; Raymond GJ; Nandan S; Lansbury PT; Caughey B
    Nature; 1995 Jun; 375(6533):698-700. PubMed ID: 7791905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of a proteinase K-sensitive PrPSc fraction.
    Pastrana MA; Sajnani G; Onisko B; Castilla J; Morales R; Soto C; Requena JR
    Biochemistry; 2006 Dec; 45(51):15710-7. PubMed ID: 17176093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No influence of amyloid-beta-degrading neprilysin activity on prion pathogenesis.
    Glatzel M; Mohajeri MH; Poirier R; Nitsch RM; Schwarz P; Lu B; Aguzzi A
    J Gen Virol; 2005 Jun; 86(Pt 6):1861-1867. PubMed ID: 15914866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein.
    Kellershohn N; Laurent M
    Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):539-45. PubMed ID: 9729459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The AGAAAAGA palindrome in PrP is required to generate a productive PrPSc-PrPC complex that leads to prion propagation.
    Norstrom EM; Mastrianni JA
    J Biol Chem; 2005 Jul; 280(29):27236-43. PubMed ID: 15917252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prion and PrPSc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene.
    Büeler H; Raeber A; Sailer A; Fischer M; Aguzzi A; Weissmann C
    Mol Med; 1994 Nov; 1(1):19-30. PubMed ID: 8790598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.